RUNX3 and metastatic malignant neoplasm in the lymph nodes: Previous findings showed that, RUNX3 was identified as a pivotal tumor-suppressor in gastric cancer (27), and a loss or substantial decrease in RUNX3 expression may be causally associated with gastric cancer, as it correlates with differentiation, lymph node metastasis and poor prognosis of this disease (28).